MIDAZOLAM 1MG/ML IN NACL 0 recalled over sterility concerns
- Recall date
- June 19, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- RXQ Compounding LLC recalls MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SYR C-IV, 55 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens,…
- Recall number
- D-1683-2019
- FDA classification
- Class II
- Brand / firm
- RXQ Compounding LLC
- Sold / distributed
- Nationwide USA
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SYR C-IV, 55 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-55
Get recall alerts
Free email alert whenever RXQ Compounding LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: RXQ Compounding LLC